🇺🇸 FDA
Patent

US 11491123

Pharmaceutical compositions with antiflaviviral activity

granted A61KA61K31/167A61K31/352

Quick answer

US patent 11491123 (Pharmaceutical compositions with antiflaviviral activity) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/167, A61K31/352, A61K31/409, A61K31/426